The Scientist

» policy and developmental biology

Most Recent

image: Pfizer-Allergan Merger Scrapped

Pfizer-Allergan Merger Scrapped

By | April 7, 2016

A move by the US federal government to close tax loopholes that encourage “tax inversions” likely spooked the companies out of the multibillion dollar deal.

0 Comments

image: A Gut Feeling

A Gut Feeling

By | April 1, 2016

See profilee Hans Clevers discuss his work with stem cells and cancer in the small intestine.

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Adjustable Brain Cells

Adjustable Brain Cells

By | February 18, 2016

Neighboring neurons can manipulate astrocytes. 

1 Comment

image: Speaking of Science 2015

Speaking of Science 2015

By | December 31, 2015

A year’s worth of noteworthy quotes

0 Comments

image: CIRM Ups Translational Velocity

CIRM Ups Translational Velocity

By | December 21, 2015

California’s stem cell agency unveiled a 5-year plan that includes starting 50 new clinical trials.

0 Comments

image: Diagnostics Group Refutes FDA’s Concerns

Diagnostics Group Refutes FDA’s Concerns

By | December 17, 2015

The Association for Molecular Pathology finds fault in the agency’s report on safety issues associated with certain lab tests.

0 Comments

image: NIH Set for Big Budget Bump

NIH Set for Big Budget Bump

By | December 17, 2015

The US National Institutes of Health would receive a $2 billion increase if the 2016 spending bill makes it through Congress unchanged.

0 Comments

image: The Cyclopes of Idaho, 1950s

The Cyclopes of Idaho, 1950s

By | December 1, 2015

A rash of deformed lambs eventually led to the creation of a cancer-fighting agent.

0 Comments

image: The Unregulation of Biotech Crops

The Unregulation of Biotech Crops

By | November 25, 2015

Genetic engineering—once a trigger for federal oversight—is now ushering some modified crops around scrutiny.

2 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS